These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8744632)

  • 21. Predisposition to thrombosis by a factor V mutation causing hereditary resistance to activated protein C.
    Press RD; Goodnight SH
    West J Med; 1995 May; 162(5):450-2. PubMed ID: 7785262
    [No Abstract]   [Full Text] [Related]  

  • 22. Arterial embolism in thyrotoxicosis with atrial fibrillation.
    Staffurth JS; Gibberd MC; Fui SN
    Br Med J; 1977 Sep; 2(6088):688-90. PubMed ID: 902055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Embolism in patients with thyrotoxic atrial fibrillation].
    Sugimoto T; Nakazawa H; Iino S; Ito K
    Nihon Naika Gakkai Zasshi; 1989 Apr; 78(4):577-8. PubMed ID: 2746090
    [No Abstract]   [Full Text] [Related]  

  • 24. Activated protein C resistance in childhood stroke.
    Ganesan V; Kelsey H; Cookson J; Osborn A; Kirkham FJ
    Lancet; 1996 Jan; 347(8996):260. PubMed ID: 8551897
    [No Abstract]   [Full Text] [Related]  

  • 25. Normalized activated protein C ratio itself not associated with increased risk of venous thromboembolism.
    Heinemann LA; Assmann A; Spannagl M; Schramm W; Dick A; Kluft C; de Maat MP
    Contraception; 1998 Nov; 58(5):321-2. PubMed ID: 9883389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients.
    Födinger M; Mannhalter C; Pabinger I; Koizar D; Rintelen C; Hörl WH; Sunder-Plassmann G
    Nephrol Dial Transplant; 1996 Apr; 11(4):668-72. PubMed ID: 8671856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of atrial fibrillation as a precursor of embolism.
    Shimomura K; Ohe T; Uehara S; Matsuhisa M; Kamakura S; Sato I
    Am J Cardiol; 1989 Jun; 63(18):1405-7. PubMed ID: 2729115
    [No Abstract]   [Full Text] [Related]  

  • 28. Should patients with atrial fibrillation be anticoagulated prior to and chronically following cardioversion?
    Stein B; Halperin JL; Fuster V
    Cardiovasc Clin; 1990; 21(1):231-47; discussion 248-9. PubMed ID: 2199050
    [No Abstract]   [Full Text] [Related]  

  • 29. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis.
    Deschiens MA; Conard J; Horellou MH; Ameri A; Preter M; Chedru F; Samama MM; Bousser MG
    Stroke; 1996 Oct; 27(10):1724-30. PubMed ID: 8841318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postpartum seizures after epidural analgesia: a patient with a mutation of the factor V Leiden and prothrombin gene.
    van Nordennen J; Camu F
    J Clin Anesth; 2007 Nov; 19(7):549-50. PubMed ID: 18063213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial fibrillation and embolic complications.
    Maru M
    East Afr Med J; 1997 Jan; 74(1):3-5. PubMed ID: 9145567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
    De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tamoxifen-associated venous thrombosis and activated protein C resistance due to factor V Leiden.
    Weitz IC; Israel VK; Liebman HA
    Cancer; 1997 May; 79(10):2024-7. PubMed ID: 9149031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Predictors of intracardiac thrombosis in patients with atrial fibrillation: factors of hemostasis, markers of inflammation, and genetic factors].
    Zotova IV; Zateĭshchikov DA; Sidorenko BA
    Kardiologiia; 2007; 47(11):46-54. PubMed ID: 18260964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Paroxysmal atrial fibrillation, a cause of systemic embolism?].
    Corbalán R; Arriagada D; Gatica A; Chadid P; Fajuri A; Chamorro G
    Rev Med Chil; 1987 May; 115(5):422-7. PubMed ID: 2966429
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pulmonary embolism disclosing activated protein C resistance].
    Strecker A; Bernardi F; Wolschies E; Hendricx S; Jude B
    Rev Mal Respir; 1996 Oct; 13(5):521-2. PubMed ID: 8999481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transient, subclinical atrial fibrillation and risk of systemic embolism in patients with rheumatic mitral stenosis in sinus rhythm.
    Karthikeyan G; Ananthakrishnan R; Devasenapathy N; Narang R; Yadav R; Seth S; Singh S; Goswami KC; Bahl VK
    Am J Cardiol; 2014 Sep; 114(6):869-74. PubMed ID: 25086468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V.
    Voorberg J; Roelse J; Koopman R; Büller H; Berends F; ten Cate JW; Mertens K; van Mourik JA
    Lancet; 1994 Jun; 343(8912):1535-6. PubMed ID: 7911872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Echocardiographic markers of embolic risk in patients with atrial fibrillation.
    Asinger RW
    G Ital Cardiol; 1994 Mar; 24(3):325-30. PubMed ID: 8063068
    [No Abstract]   [Full Text] [Related]  

  • 40. [Embolic episodes after treatment of atrial fibrillation in a patient with thyrotoxicosis].
    Hendriksen O; Petersen CL
    Ugeskr Laeger; 1995 Jul; 157(29):4138-9. PubMed ID: 7652995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.